Interleukin-based therapy for Cancer: Interleukin-1β suppresses the expression of RNA polymerase I via down regulation of its target gene, 15/March/2015, 08.16 am

MiRNA-based therapy for cancer: BMP4 suppresses the expression of RNA polymerase III via down regulation of its target gene, 15/April/2015, 7.53 am
March 15, 2015
MiRNA-based therapy for weight loss: MiRNA-577 decreases the expression of Low density lipoprotein receptor-related protein 6 and promotes weight loss via down regulation of its target gene, 15/March/2015, 08.50 pm
March 15, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Interleukin-based therapy for Cancer: Interleukin-1β suppresses the expression of RNA polymerase I via down regulation of its target gene, 15/March/2015, 08.16 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests, for the first time, that Interleukin-1β, by suppressing the expression of  its target gene, it may increase the expression of RNA polymerase I. Thereby, it may increase the proliferation of cancer cells. Thus, pharmacological formulations encompassing “Interleukin-1β activators”  can be used to inhibit the progression of human cancers. 

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How Interleukin-1β suppresses the expression of RNA polymerase I

Comments are closed.